Sunshine Biopharma Inc - Warrants (15/02/2027)
SBFMW
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.09M
Close$
Share Statistics
| Market cap | $1.09 Million |
|---|---|
| Enterprise Value | $-4,808,609.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.4 |
| Beta | 1.31 |
| Outstanding Shares | 490,595 |
Return
| Return on Equity | -28.07% |
|---|---|
| Return on Assets | -21.62% |
| Return on Invested Capital | -27.46% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | -0.46 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -0.14 |
| Enterprise Value to EBIT | 0.79 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.21 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-2.50
Average shareholder expectationRevenue Estimate
$8.09 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
$8.70 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.57%▲ 0.07% |
|---|---|
| Total Invested | $1,791▼ 39.19% |
| Investors Holding | 10% |
ESG Score
No data
About Sunshine Biopharma Inc
3 employees